vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and FARMERS NATIONAL BANC CORP (FMNB). Click either name above to swap in a different company.

FARMERS NATIONAL BANC CORP is the larger business by last-quarter revenue ($71.5M vs $38.9M, roughly 1.8× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs 20.5%, a 4.2% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 3.2%). FARMERS NATIONAL BANC CORP produced more free cash flow last quarter ($52.2M vs $19.6M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 6.2%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Farmers National Banc Corp (OH) is a regional financial holding company based in Ohio, the United States. It offers full-spectrum retail and commercial banking products, wealth management solutions, and insurance services, primarily catering to individual consumers, small and medium-sized enterprises, and local community clients in Ohio and adjacent Midwestern U.S. regions.

CDXS vs FMNB — Head-to-Head

Bigger by revenue
FMNB
FMNB
1.8× larger
FMNB
$71.5M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+78.2% gap
CDXS
81.3%
3.2%
FMNB
Higher net margin
CDXS
CDXS
4.2% more per $
CDXS
24.7%
20.5%
FMNB
More free cash flow
FMNB
FMNB
$32.6M more FCF
FMNB
$52.2M
$19.6M
CDXS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
6.2%
FMNB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
FMNB
FMNB
Revenue
$38.9M
$71.5M
Net Profit
$9.6M
$14.6M
Gross Margin
94.8%
Operating Margin
27.1%
24.8%
Net Margin
24.7%
20.5%
Revenue YoY
81.3%
3.2%
Net Profit YoY
192.5%
1.7%
EPS (diluted)
$0.13
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
FMNB
FMNB
Q4 25
$38.9M
$71.5M
Q3 25
$8.6M
$70.8M
Q2 25
$15.3M
$69.8M
Q1 25
$7.5M
$67.8M
Q4 24
$21.5M
$69.3M
Q3 24
$12.8M
$70.3M
Q2 24
$8.0M
$66.5M
Q1 24
$17.1M
$63.4M
Net Profit
CDXS
CDXS
FMNB
FMNB
Q4 25
$9.6M
$14.6M
Q3 25
$-19.6M
$12.5M
Q2 25
$-13.3M
$13.9M
Q1 25
$-20.7M
$13.6M
Q4 24
$-10.4M
$14.4M
Q3 24
$-20.6M
$8.5M
Q2 24
$-22.8M
$11.8M
Q1 24
$-11.5M
$11.2M
Gross Margin
CDXS
CDXS
FMNB
FMNB
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
FMNB
FMNB
Q4 25
27.1%
24.8%
Q3 25
-220.3%
20.7%
Q2 25
-83.9%
23.4%
Q1 25
-271.6%
24.1%
Q4 24
-34.2%
25.5%
Q3 24
-129.0%
14.4%
Q2 24
-284.9%
21.3%
Q1 24
-69.6%
21.2%
Net Margin
CDXS
CDXS
FMNB
FMNB
Q4 25
24.7%
20.5%
Q3 25
-228.1%
17.6%
Q2 25
-86.6%
19.9%
Q1 25
-274.3%
20.0%
Q4 24
-48.4%
20.8%
Q3 24
-160.8%
12.1%
Q2 24
-285.2%
17.7%
Q1 24
-67.4%
17.7%
EPS (diluted)
CDXS
CDXS
FMNB
FMNB
Q4 25
$0.13
$0.39
Q3 25
$-0.22
$0.33
Q2 25
$-0.16
$0.37
Q1 25
$-0.25
$0.36
Q4 24
$-0.12
$0.38
Q3 24
$-0.29
$0.23
Q2 24
$-0.32
$0.31
Q1 24
$-0.16
$0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
FMNB
FMNB
Cash + ST InvestmentsLiquidity on hand
$78.2M
Total DebtLower is stronger
$40.1M
$86.7M
Stockholders' EquityBook value
$50.5M
$485.7M
Total Assets
$147.8M
$5.2B
Debt / EquityLower = less leverage
0.79×
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
FMNB
FMNB
Q4 25
$78.2M
Q3 25
$58.7M
Q2 25
$66.3M
Q1 25
$59.8M
Q4 24
$73.5M
Q3 24
$90.3M
Q2 24
$73.2M
Q1 24
$85.5M
Total Debt
CDXS
CDXS
FMNB
FMNB
Q4 25
$40.1M
$86.7M
Q3 25
$39.7M
$86.6M
Q2 25
$39.4M
$86.4M
Q1 25
$29.2M
$86.3M
Q4 24
$28.9M
$86.2M
Q3 24
$28.6M
$86.0M
Q2 24
$28.4M
$88.9M
Q1 24
$28.1M
$88.8M
Stockholders' Equity
CDXS
CDXS
FMNB
FMNB
Q4 25
$50.5M
$485.7M
Q3 25
$38.5M
$465.9M
Q2 25
$55.6M
$437.7M
Q1 25
$49.6M
$429.1M
Q4 24
$66.9M
$406.0M
Q3 24
$73.4M
$439.7M
Q2 24
$61.4M
$396.7M
Q1 24
$79.3M
$397.0M
Total Assets
CDXS
CDXS
FMNB
FMNB
Q4 25
$147.8M
$5.2B
Q3 25
$124.0M
$5.2B
Q2 25
$138.2M
$5.2B
Q1 25
$128.9M
$5.2B
Q4 24
$149.0M
$5.1B
Q3 24
$148.2M
$5.2B
Q2 24
$132.0M
$5.2B
Q1 24
$149.6M
$5.1B
Debt / Equity
CDXS
CDXS
FMNB
FMNB
Q4 25
0.79×
0.18×
Q3 25
1.03×
0.19×
Q2 25
0.71×
0.20×
Q1 25
0.59×
0.20×
Q4 24
0.43×
0.21×
Q3 24
0.39×
0.20×
Q2 24
0.46×
0.22×
Q1 24
0.35×
0.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
FMNB
FMNB
Operating Cash FlowLast quarter
$20.1M
$60.0M
Free Cash FlowOCF − Capex
$19.6M
$52.2M
FCF MarginFCF / Revenue
50.3%
73.0%
Capex IntensityCapex / Revenue
1.3%
11.0%
Cash ConversionOCF / Net Profit
2.09×
4.10×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M
$85.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
FMNB
FMNB
Q4 25
$20.1M
$60.0M
Q3 25
$-7.7M
$10.7M
Q2 25
$-18.0M
$14.0M
Q1 25
$-13.8M
$15.7M
Q4 24
$-16.5M
$66.6M
Q3 24
$-13.0M
$23.9M
Q2 24
$-12.2M
$16.6M
Q1 24
$-7.8M
$13.7M
Free Cash Flow
CDXS
CDXS
FMNB
FMNB
Q4 25
$19.6M
$52.2M
Q3 25
$-7.9M
$9.0M
Q2 25
$-20.5M
$12.4M
Q1 25
$-15.1M
$12.2M
Q4 24
$-18.2M
$54.9M
Q3 24
$-14.0M
$20.4M
Q2 24
$-12.6M
$14.4M
Q1 24
$-8.9M
$12.2M
FCF Margin
CDXS
CDXS
FMNB
FMNB
Q4 25
50.3%
73.0%
Q3 25
-91.7%
12.8%
Q2 25
-133.6%
17.8%
Q1 25
-199.6%
18.0%
Q4 24
-85.0%
79.2%
Q3 24
-109.0%
29.1%
Q2 24
-157.5%
21.6%
Q1 24
-52.2%
19.2%
Capex Intensity
CDXS
CDXS
FMNB
FMNB
Q4 25
1.3%
11.0%
Q3 25
2.1%
2.4%
Q2 25
16.4%
2.3%
Q1 25
16.7%
5.2%
Q4 24
8.3%
16.9%
Q3 24
7.8%
4.9%
Q2 24
5.0%
3.3%
Q1 24
6.6%
2.4%
Cash Conversion
CDXS
CDXS
FMNB
FMNB
Q4 25
2.09×
4.10×
Q3 25
0.86×
Q2 25
1.01×
Q1 25
1.15×
Q4 24
4.63×
Q3 24
2.80×
Q2 24
1.41×
Q1 24
1.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons